tyrosine has been researched along with Syndrome in 118 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (34.75) | 18.7374 |
| 1990's | 16 (13.56) | 18.2507 |
| 2000's | 55 (46.61) | 29.6817 |
| 2010's | 5 (4.24) | 24.3611 |
| 2020's | 1 (0.85) | 2.80 |
| Authors | Studies |
|---|---|
| Cordaro, M; Crupi, R; Cuzzocrea, S; D'Amico, R; Di Paola, R; Fusco, R; Gugliandolo, E; Impellizzeri, D; Peritore, AF; Scuto, M; Siracusa, R | 1 |
| Acikel, S; Arslantas, U; Cimen, T; Dogan, M; Ertem, AG; Yeter, E | 1 |
| Banerjee, S; Blazing, MA; Braunwald, E; Brilakis, ES; Califf, RM; Cannon, CP; de Lemos, JA; Morrow, DA; Murphy, SA; Sabatine, MS; Wiviott, SD | 1 |
| Bau, AE; de Zwart-Storm, EA; Foelster-Holst, R; Frank, J; Graziadio, C; Kamps, MA; Martin, PE; Paskulin, GA; Rosa, RF; van Geel, M; van Steensel, MA; Zen, PR | 1 |
| Blau, N; Dill, P; Jakobs, C; Schneider, J; Tekin, M; Thöny, B; Trachsel, D; Weber, P | 1 |
| Bader, B; Danek, A; De Franceschi, L; Dotti, MT; Jung, HH; Laudanna, C; Mazzucco, S; Pantaleo, A; Scardoni, G; Siciliano, A; Tomelleri, C; Walker, RH | 1 |
| Delbro, D; Fall, M; Hallsberg, L; Logadottir, Y; Peeker, R | 1 |
| Chen, PK; Chuang, WL; Hsiao, M; Hung, KS; Lai, BJ; Shih, TY; Wang, TJ | 1 |
| Brener, SJ; Cannon, CP; Demopoulos, LA; DiBattiste, PM; Gibson, CM; Murphy, SA | 1 |
| Batchelor, WB; Califf, RM; Cantor, WJ; Davidian, M; DiBattiste, PM; Dillard, P; Gretler, D; Harrington, RA; Huang, Y; Larsen, RL; Mantell, RM; Ohman, EM; Sketch, MH; Tcheng, JE; Tolleson, TR; Zhang, D; Zidar, JP | 1 |
| Braunwald, E; Cannon, CP; Demopoulos, LA; DiBattiste, PM; Gibson, CM; McCabe, CH; Morrow, DA; Murphy, SA; Sabatine, MS | 1 |
| Aydin, OF; Eken, A; Kunak, B; Tezic, T; Zorlu, P | 1 |
| Armstrong, PW; Califf, RM; Christenson, RH; Fu, Y; Harrington, RA; Hasselblad, V; Kaul, P; Mahaffey, KW; Newby, LK; Ohman, EM; Topol, EJ; Van de Werf, F | 1 |
| Bhapkar, MV; Califf, RM; Davis, CG; Granger, CB; Harrington, RA; Hochman, JS; Moliterno, DJ; Newby, LK; Simes, RJ; Topol, EJ; Van de Werf, F | 1 |
| Böhm, M; Fries, R | 1 |
| Gu, H; Neel, BG; Pao, L | 1 |
| Auer, J; Berent, R; Eber, B; Lassnig, E; Maurer, E; Weber, T | 1 |
| BRACKENRIDGE, CJ | 1 |
| CHOUFOER, JC; KASSENAAR, AA; QUERIDO, A | 1 |
| Alemao, E; Bakhai, A; Ben-Joseph, R; Collinson, JR; Flather, MD; Itzler, R; Normand, C; Stevens, W | 1 |
| Antman, EM; Bates, ER; Cohen, M; Every, NR; Ferguson, JJ; Harrington, RA; Pepine, CJ; Theroux, P | 1 |
| Huynh, T; Snapinn, S; Theroux, P; Wan, Y | 1 |
| Centola, M; Hull, KM; Kastner, DL; Mansfield, E; Shoham, NG; Wise, CA; Wood, G | 1 |
| Boden, WE; Cannon, CP; Januzzi, JL; Theroux, P | 1 |
| Antman, EM; Braunwald, E; Cannon, CP; Demopoulos, LA; DiBattiste, PM; Gibson, CM; Giugliano, RP; McCabe, CH; Morrow, DA; Murphy, SA; Rifai, N; Sabatine, MS; Wiviott, SD | 1 |
| DiBattiste, PM; Jang, IK; Januzzi, JL; Servoss, SJ; Snapinn, SM; Theroux, P; Wan, Y; Zhao, XQ | 1 |
| Hennebry, TA; Saucedo, JF | 1 |
| Barbieri, D; Ferrari, F; Ferrari, R; Guardigli, G; Parrinello, G; Percoco, G; Soukhomovskaia, O; Valgimigli, M | 1 |
| Hamm, CW; Heeschen, C; Lantelme, NH; Mitrovic, V; White, HD | 1 |
| DiBattiste, PM; Huynh, T; Pharand, C; Piazza, N; Snapinn, SM; Theroux, P; Wan, Y | 1 |
| Ardissino, D; Menozzi, A; Merlini, PA | 1 |
| Chang, ST; Cheng, NJ; Chung, CM; Yang, TY | 1 |
| Chun, KJ; Hong, TJ; Jeong, JH; Kim, JH; Park, YH; Shin, YW | 1 |
| Aroney, CN; Gunasekara, AP; Walters, DL | 1 |
| Badia, T; Bellandi, F; Dabizzi, RP; De Servi, S; Leoncini, M; Maioli, M; Politi, A; Toso, A | 1 |
| Barre, A; Czjzek, M; Peumans, WJ; Receveur-Bréchot, V; Rougé, P; Roussel, A; Van Damme, EJ | 1 |
| Bonizzoni, E; De Servi, S; Dellavalle, A; Leoncinie, M; Mariani, M; Poletti, F; Politi, A; Vandoni, P | 1 |
| Buckland, R; Judge, HM; Sastry, P; Siotia, A; Storey, RF | 1 |
| Alessi, MC; Barbou, F; Bonnet, JL; Cuisset, T; Frère, C; Hovasse, T; Quilici, J; Said, LN | 1 |
| Radke, PW; Schunkert, H | 1 |
| Münzel, TF; Post, F | 1 |
| Liu, J; Wang, J; Zhang, Q | 1 |
| Topaz, O | 1 |
| Anton-Lamprecht, I; Bohnert, A | 1 |
| Gorden, P; Grunberger, G; Zick, Y | 1 |
| Kawatsu, T; Kida, K; Machino, H; Matsuda, H; Miki, Y | 1 |
| Bay, C; Kelts, D; Ney, D; Nyhan, WL; Schneider, JA | 1 |
| Balato, N; de Crecchio, G; Federico, A; Lembo, G; Pallini, R; Sammartino, A | 1 |
| Hunziker, N | 1 |
| Rehák, A; Selim, MM; Yadav, G | 1 |
| Binder, PS; Charlton, KH; Digby, DJ; Wozniak, L | 1 |
| Grenier, A; Meister, A; New, MI; Rifkind, AB; Sassa, S; Starkman, H; Steinherz, PG; Stoner, E; Wellner, D; Wellner, VP | 1 |
| Gramet, C; Lods, F | 1 |
| Arienti, V; Baraldini, M; Barbieri, B; Gasbarrini, G; Miglio, F | 1 |
| Freese, D | 1 |
| Bevilacqua, G; Castelli, MR; Nespoli, A; Rossi, N; Salerno, F; Staudacher, C | 1 |
| Klein, LE; Nordlund, JJ | 1 |
| Arai, K; Chrousos, GP; DiGeorge, AM; Latronico, AC; Rapaport, R; Tsigos, C | 1 |
| Aramaki, S; Kato, H; Soda, H; Yoshida, I; Yukizane, S | 1 |
| al-Hazzaa, SA; al-Hemidan, AI | 1 |
| Jimenez-Acosta, F | 1 |
| Bergoend, H; Delaporte, E; le Flohic, X; Piette, F; Podglajen-Wecxsteen, O | 1 |
| Couton, JM; Richards, NG; Silverman, DN; Tu, C; Van Heeke, G | 1 |
| el-Badramany, MH; Farag, TI; Fawzy, AR | 1 |
| Adgey, AA | 1 |
| Ferguson, JJ; Lau, TK | 1 |
| Lindenfeld, J | 1 |
| Roifman, CM | 1 |
| Dachary-Prigent, J; Fressinaud, E; Freyssinet, JM; Martin, S; Martínez, MC; Meyer, D; Toti, F | 1 |
| Borzak, S; Cohen, M; Deckelbaum, LI; Diodati, JG; Harris, KE; Huynh, T; Laramée, P; Lo, MW; Sax, FL; Squire, IB; Théroux, P; Thornton, AR; Weber, S; White, HD | 1 |
| Aster, JC; Cain, D; Carroll, M; Gilliland, DG; Ilaria, RL; Sternberg, DW; Tomasson, MH; Van Etten, RA; Williams, IR | 1 |
| Galli, M; Maggioni, AP; Tavazzi, L; Vassanelli, C | 1 |
| Carman, G; Donaldson, E; Little, M | 1 |
| Zidar, JP | 1 |
| Aiuti, F; Dallapiccola, B; Digilio, MC; Giannotti, A; Giovannetti, A; Marino, B; Marziali, M; Novelli, G; Oliva, A; Pandolfi, F; Pierdominici, M; Rosso, R | 1 |
| Blankenship, JC; Frey, CM; Memon, MA; Menapace, FJ; Wood, GC | 1 |
| Jang, IK; Sabatine, MS | 1 |
| Holmes, DR | 1 |
| Agustí, A; Araujo, R | 1 |
| Alexander, J; Barr, E; Dupuis, J; Gervais, P; Grandmont, D; Huynh, T; Kouz, S; Laramée, P; Pesant, Y; Sax, FL; Théroux, P | 1 |
| Auer, J; Berent, R; Eber, B; Maurer, E; Mayr, H; Weber, T | 1 |
| Goldmann, BU; Hamm, CW | 1 |
| Popma, JJ; Suk, J | 1 |
| Galli, M; Vassanelli, C | 1 |
| Houghton, AR; Hudson, I; Patel, M | 1 |
| Chew, DP; Moliterno, DJ | 1 |
| Antman, EM; Braunwald, E; McCabe, CH; Morrow, DA; Snapinn, SM; Theroux, P | 1 |
| SoRelle, R | 1 |
| Anderson, N; Clayton, PE; Freeth, JS; Huynh, T; Kloth, MT; Laughlin, KK; Silva, CM; Whatmore, AJ; Woodall, AJ | 1 |
| Bhatt, DL; Chew, DP | 1 |
| Bardelli, AM; Borgogni, P; Farnetani, MA; Fois, A; Frezzotti, R; Mattei, R; Molinelli, M; Sargentini, I | 1 |
| Goldsmith, LA | 3 |
| Goddé-Jolly, D; Larregue, M; Roussat, B; Van Effenterre, G | 1 |
| Goldsmith, LA; Roe, CR; Thorpe, J | 1 |
| Goldsmith, LA; Reed, J | 1 |
| Gallasch, G; Jaeger, W; Lutz, P; Schmidt, H; Schnyder, UW | 2 |
| Antener, I; Faggioni, R; Gautier, E; Pelet, B; Spahr, A | 1 |
| Bienfang, DC; Kuwabara, T; Pueschel, SM | 1 |
| Bressieux, JM; de Giacomoni, P; Larrègue, M; Odièvre, M | 1 |
| Christensen, K; Fischer, P; Knudsen, KE; Larsen, S; Sørensen, H; Venge, O | 1 |
| Finegold, MJ | 1 |
| Ritsner, MS | 1 |
| Chalmers, RA; Lawson, AM; Liberman, MM; Watts, RW | 1 |
| Ito, K; Ito, M; Maruyama, T; Nakamura, A; Sato, Y; Shimizu, N | 1 |
| D'Hermies, F; Dufier, JL; Foels, MO; Gounod, N; Pouliquen, Y; Renard, G | 1 |
| Basić, V; Cerkez, A; Hrnjica, M; Lazović, O; Popović, N; Salamon, T; Schnyder, UW; Softić, M; Stolić, V; Topić, B | 1 |
| Babbini, N; Crovato, F; Desirello, G; Gatti, R; Rebora, A | 1 |
| Mantz, JM; Metais, P; Oberling, F; Storck, D; Warter, J | 1 |
| Holmgren, G; Nordström, S; Thorburn, W | 1 |
| Buxton, BH; Curzon, G; Fenton, G; Kantamaneni, BD; Parkes, JD; Record, C; Struthers, G | 1 |
| Hill, A; Zaleski, WA | 1 |
| Ginsburg, AD; Godwin, HA | 1 |
| Desnick, S; Jackson, CE; Nance, WE; White, JG; Witkop, CJ | 1 |
23 review(s) available for tyrosine and Syndrome
| Article | Year |
|---|---|
[Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure].
Topics: Abciximab; Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Antibodies, Monoclonal; Anticholesteremic Agents; Arrhythmias, Cardiac; Aspirin; Atorvastatin; Clopidogrel; Defibrillators, Implantable; Double-Blind Method; Fibrinolytic Agents; Heart Failure; Heart Septal Defects, Atrial; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Myocardial Infarction; Placebos; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrroles; Quality of Life; Randomized Controlled Trials as Topic; Regeneration; Risk Factors; Syndrome; Ticlopidine; Time Factors; Tirofiban; Tyrosine | 2003 |
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.
Topics: Animals; Binding Sites; Humans; Intracellular Signaling Peptides and Proteins; Leukemia; Mutation; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatases; SH2 Domain-Containing Protein Tyrosine Phosphatases; Signal Transduction; src Homology Domains; Syndrome; Tyrosine | 2003 |
[Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
Topics: Abciximab; Administration, Oral; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Controlled Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combination; Electrocardiography; Emergencies; Eptifibatide; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Stents; Syndrome; Thrombocytopenia; Thrombolytic Therapy; Time Factors; Tirofiban; Tyrosine | 2003 |
Optimizing glycoprotein IIb/IIIa receptor antagonist use for the non-ST-segment elevation acute coronary syndromes: risk stratification and therapeutic intervention.
Topics: Abciximab; Acute Disease; Aged; Antibodies, Monoclonal; Coronary Disease; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Assessment; Syndrome; Tirofiban; Tyrosine | 2003 |
Use of the early invasive approach in the management of acute coronary syndromes.
Topics: Angina, Unstable; Cardiac Catheterization; Humans; Myocardial Infarction; Myocardial Revascularization; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Assessment; Syndrome; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
Tirofiban in acute coronary syndromes.
Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine | 2005 |
[Antithrombotic treatment of acute coronary syndromes without ST-segment elevation].
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Clopidogrel; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Syndrome; Ticlopidine; Tirofiban; Tyrosine | 2006 |
[Pathogenesis and therapy of the acute coronary syndrome: differentiated advantage of glycoprotein IIb/IIIa receptor antagonists for high-risk patients].
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Coronary Thrombosis; Diabetes Complications; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Renal Insufficiency; Risk Factors; Syndrome; Ticlopidine; Tirofiban; Troponin; Tyrosine | 2006 |
Intracellular cholestatic syndromes of infancy.
Topics: Bacterial Infections; Bile Acids and Salts; Biopsy, Needle; Cholestasis, Intrahepatic; Fructose; Galactose; Glycogen Storage Disease; Hepatitis; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Liver; Metabolism, Inborn Errors; Prognosis; Syndrome; Tyrosine | 1982 |
Richner-Hanhart syndrome (tyrosinemia type II). Case report and literature review.
Topics: Amino Acid Metabolism, Inborn Errors; Child; Consanguinity; Cornea; Corneal Opacity; Diagnosis, Differential; Female; Humans; Intellectual Disability; Keratitis; Keratitis, Herpetic; Keratoderma, Palmoplantar; Liver; Syndrome; Tyrosine; Tyrosine Transaminase; Visual Acuity | 1995 |
An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Eptifibatide; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Treatment Outcome; Tyrosine | 1998 |
New antiplatelet agents for acute coronary syndromes.
Topics: Abciximab; Acetates; Acute Disease; Antibodies, Monoclonal; Blood Platelets; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Injections, Intravenous; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine | 1998 |
[The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].
Topics: Acute Disease; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Eptifibatide; Humans; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Syndrome; Tirofiban; Tyrosine | 2000 |
Glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes.
Topics: Abciximab; Acetates; Acute Disease; Antibodies, Monoclonal; Humans; Immunoglobulin Fab Fragments; Myocardial Ischemia; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine | 1999 |
Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis of major clinical trials.
Topics: Abciximab; Acetates; Acute Disease; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Coronary Disease; Drug Therapy, Combination; Eptifibatide; Heparin; Humans; Immunoglobulin Fab Fragments; Incidence; Infusions, Intravenous; Intracranial Hemorrhages; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Syndrome; Tirofiban; Tyrosine | 2000 |
The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.
Topics: Abciximab; Acetates; Acute Disease; Administration, Oral; Alanine; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Coronary Disease; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Oximes; Peptides; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Randomized Controlled Trials as Topic; Stents; Syndrome; Thrombocytopenia; Thrombolytic Therapy; Tirofiban; Tyrosine | 2000 |
Platelet glycoprotein receptor site blockade in coronary artery disease.
Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stents; Syndrome; Tirofiban; Treatment Outcome; Tyrosine | 2000 |
[Acute coronary syndromes: an update. I. Pathogenesis and drug therapy].
Topics: Acute Disease; Administration, Oral; Adrenergic beta-Antagonists; Angina, Unstable; Anticoagulants; Aspirin; Calcium Channel Blockers; Clinical Trials as Topic; Clopidogrel; Electrocardiography; Fibrinolytic Agents; Humans; Multicenter Studies as Topic; Myocardial Infarction; Nitrates; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Syndrome; Terminology as Topic; Ticlopidine; Tirofiban; Tyrosine | 2001 |
Use of coronary revascularization in patients with unstable and non-ST-segment elevation acute myocardial infarction.
Topics: Angina, Unstable; Humans; Myocardial Infarction; Myocardial Revascularization; Randomized Controlled Trials as Topic; Risk Assessment; Syndrome; Thrombolytic Therapy; Tirofiban; Tyrosine | 2001 |
GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us.
Topics: Abciximab; Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Atherectomy; Clinical Trials as Topic; Coronary Disease; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Placebos; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Syndrome; Time Factors; Tirofiban; Treatment Outcome; Troponin T; Tyrosine | 2001 |
Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials.
Topics: Abciximab; Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Drug Administration Schedule; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Syndrome; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2002 |
Tyrosine-induced skin disease.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Corneal Ulcer; Diagnosis, Differential; Disease Models, Animal; Female; Humans; Infant; Keratoderma, Palmoplantar; Male; Rats; Syndrome; Tyrosine | 1978 |
Cholestatic syndromes in infancy.
Topics: Anemia, Hemolytic; Bile; Bile Ducts; Cholestasis; Chromosome Aberrations; Chromosome Disorders; Fasting; Fructose Intolerance; Galactosemias; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Infections; Jaundice, Neonatal; Liver; Liver Cirrhosis; Niemann-Pick Diseases; Nutritional Physiological Phenomena; Syndrome; Tyrosine | 1976 |
19 trial(s) available for tyrosine and Syndrome
| Article | Year |
|---|---|
Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials).
Topics: Atorvastatin; Coronary Artery Bypass; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Care; Pravastatin; Pyrroles; Retrospective Studies; Simvastatin; Syndrome; Thrombolytic Therapy; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2008 |
Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes.
Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Disease; Coronary Vessels; Female; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Severity of Illness Index; Survival Analysis; Syndrome; Tirofiban; Treatment Outcome; Tyrosine | 2002 |
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, an
Topics: Abciximab; Acute Disease; Aged; Amino Acid Chloromethyl Ketones; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Citric Acid; Coronary Disease; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Kinetics; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine | 2002 |
Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservati
Topics: Acute Disease; Aged; Angina Pectoris; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Fees, Pharmaceutical; Female; Fibrinolytic Agents; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Severity of Illness Index; Smoking; Statistics as Topic; Stroke Volume; Survival Analysis; Syndrome; Tirofiban; Tyrosine | 2002 |
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients.
Topics: Acetates; Acute Disease; Aged; Coronary Disease; Electrocardiography; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Risk Assessment; Syndrome; Time Factors; Troponin T; Tyrosine | 2003 |
An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A.
Topics: Acetates; Acute Disease; Aged; Aged, 80 and over; Coronary Disease; Female; Heparin; Humans; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Monitoring, Physiologic; Odds Ratio; Partial Thromboplastin Time; Point-of-Care Systems; Syndrome; Tyrosine | 2002 |
National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom.
Topics: Aged; Angina, Unstable; Anticoagulants; Cardiac Catheterization; Coronary Angiography; Coronary Disease; Electrocardiography; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Patient Admission; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Prospective Studies; Risk Factors; Sensitivity and Specificity; Syndrome; Tirofiban; Treatment Outcome; Tyrosine; United Kingdom | 2003 |
Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.
Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Coronary Disease; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Female; Fibrinolytic Agents; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine | 2003 |
Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
Topics: Aged; Angina, Unstable; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sex Factors; Syndrome; Tirofiban; Tyrosine | 2003 |
Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombo
Topics: Acute Disease; Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Combined Modality Therapy; Creatine Kinase; Creatine Kinase, MB Form; Female; Fibrinolytic Agents; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Sex Factors; Syndrome; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Troponin; Tyrosine | 2004 |
Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial.
Topics: Acute Disease; Angina Pectoris; Coronary Artery Bypass; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Myocardial Infarction; Myocardial Ischemia; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial.
Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Biomarkers; Coronary Stenosis; Creatine Kinase; Creatine Kinase, MB Form; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heparin; Humans; Intraoperative Complications; Isoenzymes; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prevalence; Risk Factors; Syndrome; Tirofiban; Treatment Outcome; Troponin I; Tyrosine | 2004 |
N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
Topics: Acute Disease; Anticoagulants; Aspirin; Biomarkers; C-Reactive Protein; Drug Therapy, Combination; Follow-Up Studies; Heparin; Humans; Incidence; Myocardial Infarction; Myocardial Ischemia; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Predictive Value of Tests; Risk; Risk Assessment; Syndrome; Tirofiban; Troponin T; Tyrosine | 2004 |
Effects of tirofiban plus clopidogrel versus clopidogrel plus provisional abciximab on biomarkers of myocardial necrosis in patients with non-ST-elevation acute coronary syndromes treated with early aggressive approach. Results of the CLOpidogrel, upstrea
Topics: Abciximab; Acute Disease; Aged; Angina, Unstable; Antibodies, Monoclonal; Clopidogrel; Creatine Kinase, MB Form; Electrocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Myocardial Infarction; Necrosis; Prospective Studies; Syndrome; Ticlopidine; Time Factors; Tirofiban; Troponin I; Tyrosine | 2005 |
Utility of a whole blood single platelet counting assay to monitor the effects of tirofiban in patients with acute coronary syndromes scheduled for coronary intervention.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Drug Monitoring; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Prospective Studies; Syndrome; Tirofiban; Tyrosine | 2006 |
Combination therapy with tirofiban and enoxaparin in acute coronary syndromes.
Topics: Angina, Unstable; Coronary Angiography; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Injections, Intravenous; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Safety; Syndrome; Tirofiban; Treatment Outcome; Tyrosine | 1999 |
Upstream use of tirofiban in patients admitted for an acute coronary syndrome in hospitals with or without facilities for invasive management. PRISM-PLUS Investigators.
Topics: Acute Disease; Aged; Angina, Unstable; Anticoagulants; Canada; Cardiac Catheterization; Double-Blind Method; Female; Heparin; Hospitals; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Survival Analysis; Syndrome; Tirofiban; Treatment Outcome; Tyrosine | 2001 |
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS.
Topics: Acute Disease; Aged; Angina, Unstable; Anticoagulants; Biomarkers; Coronary Disease; Creatine Kinase; Creatine Kinase, MB Form; Electrocardiography; Endpoint Determination; Follow-Up Studies; Heparin; Humans; Isoenzymes; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Risk Assessment; Survival Analysis; Syndrome; Tirofiban; Treatment Outcome; Tyrosine | 2002 |
Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes.
Topics: Acetates; Acute Disease; Aged; Coronary Disease; Double-Blind Method; Endpoint Determination; Female; Hemorrhage; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Titrimetry; Treatment Outcome; Tyrosine | 2002 |
76 other study(ies) available for tyrosine and Syndrome
| Article | Year |
|---|---|
Modulation of NLRP3 Inflammasome through Formyl Peptide Receptor 1 (Fpr-1) Pathway as a New Therapeutic Target in Bronchiolitis Obliterans Syndrome.
Topics: Animals; Apoptosis; Bronchiolitis Obliterans; Caspase 1; Cell Count; Enzyme Activation; Inflammasomes; Intercellular Signaling Peptides and Proteins; Interleukin-18; Interleukin-1beta; Male; Mast Cells; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Molecular Targeted Therapy; Nitric Oxide Synthase Type II; NLR Family, Pyrin Domain-Containing 3 Protein; Poly(ADP-ribose) Polymerases; Receptors, Formyl Peptide; Signal Transduction; Syndrome; Tyrosine | 2020 |
From treatment to diagnosis of Kounis syndrome in the catherization laboratory: the resolution of vasospastic angina after intracoronary tirofiban and nitrate therapy.
Topics: Acute Coronary Syndrome; Cardiac Catheterization; Coronary Vasospasm; Coronary Vessels; Humans; Hypersensitivity; Male; Middle Aged; Nitrates; Syndrome; Tirofiban; Tyrosine | 2013 |
Molecular analysis of connexin26 asparagine14 mutations associated with syndromic skin phenotypes.
Topics: Adult; Asparagine; Aspartic Acid; Cell Membrane; Child; Connexin 26; Connexins; Cytoplasm; Endoplasmic Reticulum; Female; Fluoresceins; Gap Junctions; Hearing Loss; HeLa Cells; Humans; Hypertrichosis; Keratoderma, Palmoplantar; Keratosis; Lysine; Male; Mutation, Missense; Nails, Malformed; Protein Transport; Skin; Skin Diseases; Syndrome; Transfection; Tyrosine | 2011 |
Pyridoxal phosphate-responsive seizures in a patient with cerebral folate deficiency (CFD) and congenital deafness with labyrinthine aplasia, microtia and microdontia (LAMM).
Topics: Base Sequence; Child; Codon, Nonsense; Congenital Abnormalities; Congenital Microtia; Dihydroxyphenylalanine; DNA Primers; Ear; Ear, Inner; Electroencephalography; Epilepsy; Fibroblast Growth Factor 3; Folate Receptor 1; Folic Acid Deficiency; Humans; Levodopa; Male; Molecular Sequence Data; Pyridoxal Phosphate; Radiography; Sequence Analysis, DNA; Skull; Syndrome; Tooth Abnormalities; Tyrosine | 2011 |
Computational identification of phospho-tyrosine sub-networks related to acanthocyte generation in neuroacanthocytosis.
Topics: Acanthocytes; Blotting, Western; Chorea; Computational Biology; Humans; Neuroacanthocytosis; Phosphorylation; Protein Interaction Maps; Protein-Tyrosine Kinases; Proteomics; Syndrome; Tyrosine | 2012 |
Bladder pain syndrome/interstitial cystitis ESSIC type 3C: high expression of inducible nitric oxide synthase in inflammatory cells.
Topics: Biomarkers; Biopsy; Cystitis, Interstitial; Humans; Inflammation; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type II; Retrospective Studies; Syndrome; Tyrosine; Urinary Bladder; Urinary Bladder Diseases; Urothelium | 2013 |
Beare-Stevenson cutis gyrata syndrome with Chiari malformation.
Topics: Abnormalities, Multiple; Adult; Amino Acid Substitution; Arnold-Chiari Malformation; Craniosynostoses; Cystine; Female; Humans; Hydrocephalus; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Postoperative Complications; Pregnancy; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Reoperation; Syndrome; Tomography, X-Ray Computed; Tyrosine; Ultrasonography, Prenatal | 2002 |
Two siblings with tyrosinaemia type 2.
Topics: Amino Acid Metabolism, Inborn Errors; Child; Child, Preschool; Conjunctivitis; Diagnosis, Differential; Female; Foot Dermatoses; Humans; Keratosis; Male; Photophobia; Syndrome; Tyrosine | 2003 |
The tyrosine and tryptophan content of blood serum in malignant disease.
Topics: Hematologic Diseases; Humans; Neoplasms; Serum; Syndrome; Tryptophan; Tyrosine | 1960 |
The syndrome of congenital hypothyroidism with defective dehalogenation of iodotyrosines. Further observations and a discussion of the pathophysiology.
Topics: Congenital Hypothyroidism; Humans; Hypothyroidism; Monoiodotyrosine; Syndrome; Tyrosine | 1960 |
Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway.
Topics: Cell Cycle Proteins; Cell Line; Cytoskeletal Proteins; Familial Mediterranean Fever; Glutathione Transferase; Granulocytes; GTP-Binding Proteins; HeLa Cells; Humans; Inflammation; Interleukin-1; Leukocytes, Mononuclear; Microscopy, Fluorescence; Monocytes; Mutation; Phosphorylation; Plasmids; Precipitin Tests; Protein Binding; Protein Structure, Tertiary; Proteins; Proto-Oncogene Proteins c-abl; Pyrin; src Homology Domains; Syndrome; Transfection; Two-Hybrid System Techniques; Tyrosine | 2003 |
Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: insights from the PRISM-PLUS study.
Topics: Aged; Angina, Unstable; Anticoagulants; Drug Therapy, Combination; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Syndrome; Tirofiban; Tyrosine | 2005 |
Restoration of normal coronary flow with tirofiban by intracoronary administration for no-reflow phenomenon after stent deployment.
Topics: Aged; Coronary Circulation; Coronary Disease; Humans; Infusions, Intravenous; Male; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Syndrome; Tirofiban; Tyrosine | 2005 |
Safety of tirofiban therapy in korean patients with acute coronary syndrome.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Disease; Drug Evaluation; Female; Humans; Korea; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Syndrome; Tirofiban; Tyrosine | 2005 |
Comparison of abciximab with "high-dose" tirofiban in patients undergoing percutaneous coronary intervention.
Topics: Abciximab; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Australia; Diabetic Angiopathies; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Syndrome; Tirofiban; Troponin; Tyrosine | 2006 |
Crystal structure at 1.45-A resolution of the major allergen endo-beta-1,3-glucanase of banana as a molecular basis for the latex-fruit syndrome.
Topics: Allergens; Amino Acid Sequence; Binding Sites; Catalysis; Catalytic Domain; Cross Reactions; Crystallography, X-Ray; Epitopes; Epitopes, B-Lymphocyte; Food Hypersensitivity; Fruit; Glucan Endo-1,3-beta-D-Glucosidase; Glucose; Glutamic Acid; Immunoglobulin E; Latex; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Musa; Phenylalanine; Polysaccharides; Protein Binding; Protein Conformation; Protein Structure, Secondary; Proteins; Proteomics; Substrate Specificity; Syndrome; Time Factors; Triose-Phosphate Isomerase; Tyrosine | 2006 |
Use of glycoprotein IIb/IIIa inhibitors in invasively-treated patients with non-ST elevation acute coronary syndrome.
Topics: Abciximab; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Coronary Angiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Registries; Stents; Syndrome; Tirofiban; Tyrosine | 2006 |
[Platelet function after a high dose bolus of tirofiban immediately after coronary angioplasty].
Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Syndrome; Time Factors; Tirofiban; Tyrosine | 2006 |
FOXL2 mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
Topics: Asian People; Blepharophimosis; Blepharoptosis; Cysteine; Cytosine; Eye Abnormalities; Eyelids; Forkhead Box Protein L2; Forkhead Transcription Factors; Guanine; Heterozygote; Histidine; Humans; Mutation; Mutation, Missense; Polymorphism, Single-Stranded Conformational; Serine; Syndrome; Thymine; Tyrosine | 2007 |
Ischemic coronary syndromes and SVG Interventions--do 2b/3a inhibitors miss the target?
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Coronary Disease; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine; Venous Thrombosis | 2007 |
Richner-Hanhart's syndrome: ultrastructural abnormalities of epidermal keratinization indicating a causal relationship to high intracellular tyrosine levels.
Topics: Adult; Child; Corneal Dystrophies, Hereditary; Female; Humans; Intellectual Disability; Keratoderma, Palmoplantar; Male; Middle Aged; Pedigree; Skin; Skin Abnormalities; Syndrome; Tyrosine; Tyrosine Transaminase | 1982 |
Defect in phosphorylation of insulin receptors in cells from an insulin-resistant patient with normal insulin binding.
Topics: Caseins; Female; Glutamates; Glutamic Acid; Humans; Insulin; Insulin Resistance; Monocytes; Phosphorylation; Protein Kinases; Receptor, Insulin; Syndrome; Tyrosine | 1984 |
Successful dietary control of tyrosinemia II.
Topics: Amino Acid Metabolism, Inborn Errors; Child, Preschool; Corneal Opacity; Female; Humans; Keratins; Keratoderma, Palmoplantar; Phenylacetates; Phenylalanine; Phenylpropionates; Phenylpyruvic Acids; Syndrome; Tyrosine; Tyrosine Transaminase | 1983 |
Dietary management of oculocutaneous tyrosinemia in an 11-year-old child.
Topics: Adolescent; Adult; Ambulatory Care; Child; Child, Preschool; Female; Humans; Infant; Intellectual Disability; Keratitis; Keratoderma, Palmoplantar; Male; Phenylalanine; Seasons; Syndrome; Tyrosine | 1983 |
Familial Richner-Hanhart syndrome: genetic, clinical, and metabolic studies.
Topics: Adolescent; Adult; Child; Corneal Opacity; Eye Diseases; Female; Humans; Keratitis, Dendritic; Keratoderma, Palmoplantar; Male; Pedigree; Syndrome; Tyrosine | 1984 |
Richner-Hanhart syndrome and tyrosinemia type II.
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Female; Humans; Keratitis; Keratoderma, Palmoplantar; Male; Pedigree; Syndrome; Tyrosine | 1980 |
Richner-Hanhart syndrome (tyrosinaemia-II) (report of four cases without ocular involvement).
Topics: Adolescent; Adult; Amino Acid Metabolism, Inborn Errors; Child; Female; Humans; Keratoderma, Palmoplantar; Male; Pedigree; Syndrome; Tyrosine | 1981 |
Pseudodendritic keratitis and systemic tyrosinemia.
Topics: Amino Acid Metabolism, Inborn Errors; Female; Humans; Infant; Keratitis, Dendritic; Keratoderma, Palmoplantar; Male; Syndrome; Tyrosine | 1981 |
Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: evidence of glutathione deficiency.
Topics: Erythrocytes; Fanconi Syndrome; Female; Glutathione; Heme; Humans; Infant; Liver; Liver Diseases; Mass Spectrometry; Mixed Function Oxygenases; Phosphates; Pyrroles; Rickets; Syndrome; Tyrosine | 1984 |
[Richner-Hanart syndrome without skin involvement].
Topics: Amino Acid Metabolism, Inborn Errors; Eye Diseases; Female; Humans; Infant; Syndrome; Tyrosine | 1984 |
[Effects of tiropramide on gallbladder emptying in patients with a dyspeptic syndrome associated with biliary dyskinesia].
Topics: Adolescent; Adult; Aged; Biliary Dyskinesia; Dyspepsia; Female; Gallbladder; Humans; Male; Middle Aged; Syndrome; Tyrosine | 1984 |
Pathogenesis of hepatic encephalopathy and hyperdynamic syndrome in cirrhosis. Role of false neurotransmitters.
Topics: Adolescent; Adult; Aged; Amino Acids; Cardiac Output; Female; Hemodynamics; Hepatic Encephalopathy; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Octopamine; Phenylalanine; Syndrome; Tryptophan; Tyrosine; Vascular Resistance | 1981 |
Genetic basis of pigmentation and its disorders.
Topics: Albinism; Animals; Cell Differentiation; Color; Humans; Lentigo; Melanins; Melanocytes; Melanoma; Mice; Monophenol Monooxygenase; Nevus; Phenylalanine; Pigmentation; Pigmentation Disorders; Skin; Syndrome; Tyrosine | 1981 |
A novel mutation of the adrenocorticotropin receptor (ACTH-R) gene in a family with the syndrome of isolated glucocorticoid deficiency, but no ACTH-R abnormalities in two families with the triple A syndrome.
Topics: Adenine; Adolescent; Adult; Amino Acid Sequence; Base Sequence; Cell Membrane; Cysteine; DNA; DNA Primers; Female; Genes, Recessive; Genetic Carrier Screening; Genetic Diseases, Inborn; Glucocorticoids; Guanine; Homozygote; Humans; Male; Middle Aged; Molecular Sequence Data; Pedigree; Point Mutation; Polymerase Chain Reaction; Protein Structure, Secondary; Receptors, Corticotropin; Syndrome; Tyrosine | 1995 |
Carbonic anhydrase II deficiency in a Japanese patient produced by a nonsense mutation (TAT-->TAG) at Tyr-40 in exon 2, (Y40X).
Topics: Acidosis, Renal Tubular; Adult; Brain Diseases; Calcinosis; Carbonic Anhydrases; Clone Cells; DNA Mutational Analysis; Exons; Female; Humans; Intellectual Disability; Japan; Mutation; Polymerase Chain Reaction; Syndrome; Tyrosine | 1995 |
Painful plantar callouses and mental retardation. Tyrosinemia type II.
Topics: Bony Callus; Corneal Ulcer; Humans; Intellectual Disability; Keratoderma, Palmoplantar; Male; Middle Aged; Pain; Syndrome; Tyrosine; Tyrosine Transaminase | 1994 |
[Oculocutaneous type II tyrosinosis].
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Humans; Intellectual Disability; Keratitis; Keratoderma, Palmoplantar; Male; Syndrome; Tyrosine | 1993 |
Kinetic analysis of a mutant (His107-->Tyr) responsible for human carbonic anhydrase II deficiency syndrome.
Topics: Animals; Base Sequence; Carbonic Anhydrases; Catalysis; Cattle; Cloning, Molecular; DNA; Escherichia coli; Histidine; Humans; Hydrogen-Ion Concentration; Kinetics; Models, Molecular; Molecular Sequence Data; Mutation; Protein Conformation; Syndrome; Tyrosine | 1993 |
Familial richner-Hanhart syndrome in Kuwait: twelve-year clinical reassessment by a multidisciplinary approach.
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Female; Humans; Intellectual Disability; Keratoderma, Palmoplantar; Kuwait; Male; Pedigree; Point Mutation; Syndrome; Tyrosine; Tyrosine Transaminase | 1995 |
Two new antiplatelet drugs for angioplasty and acute coronary syndromes.
Topics: Abciximab; Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Disease; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Premedication; Syndrome; Tirofiban; Tyrosine | 1998 |
Safety and effectiveness of inhaled nitric oxide and tirofiban for acute coronary syndromes: a report from the cardiovascular and renal advisory panel of the food and drug administration.
Topics: Acute Disease; Administration, Inhalation; Coronary Disease; Humans; Nitric Oxide; Platelet Aggregation Inhibitors; Syndrome; Tirofiban; Tyrosine; United States; United States Food and Drug Administration; Vasodilator Agents | 1998 |
Antibody deficiency, growth retardation, spondyloepiphyseal dysplasia and retinal dystrophy: a novel syndrome.
Topics: Abnormalities, Multiple; Adult; Child; Child, Preschool; Fetal Growth Retardation; Humans; Immunologic Deficiency Syndromes; Male; Musculoskeletal Abnormalities; Phosphorylation; Receptors, Antigen, B-Cell; Retina; Syndrome; Tyrosine | 1999 |
Significance of capacitative Ca2+ entry in the regulation of phosphatidylserine expression at the surface of stimulated cells.
Topics: Aged; B-Lymphocytes; Blood Coagulation Disorders; Calcimycin; Calcium Channels; Cell Membrane; Cell Transformation, Viral; Cells, Cultured; Enzyme Inhibitors; Female; Genistein; Humans; Lymphocyte Activation; Phosphatidylserines; Phospholipids; Phosphorylation; Protein-Tyrosine Kinases; Syndrome; Thapsigargin; Tyrosine | 1999 |
Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581.
Topics: Animals; Cell Transformation, Neoplastic; Clone Cells; DNA-Binding Proteins; ETS Translocation Variant 6 Protein; Gene Rearrangement, T-Lymphocyte; Gene Transfer Techniques; Genetic Vectors; Leukemia, Myelomonocytic, Acute; Lymphoma, T-Cell; Mice; Mice, Inbred BALB C; Oncogene Proteins, Fusion; Proto-Oncogene Proteins c-ets; Receptors, Platelet-Derived Growth Factor; Repressor Proteins; Retroviridae; Signal Transduction; Syndrome; Tissue Transplantation; Transcription Factors; Tyrosine; Virus Integration | 2000 |
Novel WT1 exon 9 mutation (D396Y) in a patient with early onset Denys Drash syndrome.
Topics: Amino Acid Substitution; Aspartic Acid; Child, Preschool; DNA-Binding Proteins; Exons; Fatal Outcome; Genes, Wilms Tumor; Humans; Infant, Newborn; Male; Mutation, Missense; Syndrome; Transcription Factors; Tyrosine; Urogenital Abnormalities; WT1 Proteins | 2000 |
T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome.
Topics: Abnormalities, Multiple; Apoptosis; CD3 Complex; Cell Division; DiGeorge Syndrome; Immunophenotyping; Mitogens; Oncostatin M; Peptides; Phosphorylation; Phytohemagglutinins; Receptors, Antigen, T-Cell, alpha-beta; Syndrome; T-Lymphocytes; Tyrosine | 2000 |
[Therapy of acute coronary syndrome with glycoprotein IIb/IIIa antagonists].
Topics: Abciximab; Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Atherectomy; Clinical Trials as Topic; Combined Modality Therapy; Coronary Disease; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Syndrome; Tirofiban; Tyrosine; United States; United States Food and Drug Administration | 2000 |
[Risk stratification in acute coronary syndrome].
Topics: Abciximab; Acute Disease; Angina, Unstable; Antibodies, Monoclonal; Anticoagulants; Biomarkers; Clinical Trials as Topic; Coronary Disease; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Nadroparin; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Retrospective Studies; Risk Factors; Syndrome; Terminology as Topic; Tirofiban; Troponin I; Troponin T; Tyrosine | 2001 |
[Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban].
Topics: Coronary Disease; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Syndrome; Time Factors; Tirofiban; Tyrosine | 2001 |
Cost implications of routine tirofiban use in the management of acute coronary syndromes.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Coronary Disease; Eligibility Determination; Female; Health Care Costs; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Random Allocation; Syndrome; Tirofiban; Tyrosine | 2001 |
Platelet glycoprotein IIb/IIIa inhibitor effect examined in 2 studies.
Topics: Acetates; Acute Disease; Angina, Unstable; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Eptifibatide; Humans; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Syndrome; Treatment Outcome; Tyrosine | 2002 |
GH and epidermal growth factor signaling in normal and Laron syndrome fibroblasts.
Topics: Abnormalities, Multiple; Androstadienes; Blotting, Western; Child; Epidermal Growth Factor; Female; Fibroblasts; Growth Hormone; Humans; Indicators and Reagents; Janus Kinase 2; Luciferases; Mitogen-Activated Protein Kinases; Phosphorylation; Precipitin Tests; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, Somatotropin; Signal Transduction; Syndrome; Transfection; Tyrosine; Wortmannin | 2002 |
Familial tyrosinaemia with eye and skin lesions. Presentation of two cases.
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Child, Preschool; Corneal Diseases; Female; Humans; Infant; Keratoderma, Palmoplantar; Male; Syndrome; Tyrosine; Tyrosine Transaminase | 1977 |
Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome).
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Child; Crystallization; Disease Models, Animal; Eye Diseases; Female; Hemolysis; Heterozygote; Humans; In Vitro Techniques; Infant; Infant, Newborn; Intellectual Disability; Liver; Lysosomes; Male; Rats; Skin Diseases; Syndrome; Tyrosine; Tyrosine Transaminase | 1978 |
[A case of Richner-Hanhart syndrome (tyrosinosis with ocular, cutaneous and mental manifestations].
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Child, Preschool; Corneal Opacity; Female; Humans; Infant; Infant, Newborn; Intellectual Disability; Keratoconjunctivitis; Keratoderma, Palmoplantar; Rats; Syndrome; Tyrosine; Tyrosine Transaminase; Vision Disorders | 1979 |
Hepatic enzymes of tyrosine metabolism in tyrosinemia II.
Topics: Amino Acid Metabolism, Inborn Errors; Aspartate Aminotransferases; Foot Dermatoses; Humans; Keratoderma, Palmoplantar; Liver; Male; Middle Aged; Syndrome; Tyrosine; Tyrosine Transaminase | 1979 |
Tyrosine-induced eye and skin lesions. A treatable genetic disease.
Topics: Female; Growth Disorders; Humans; Infant; Intellectual Disability; Keratoderma, Palmoplantar; Syndrome; Tyrosine | 1976 |
[Herpetiform bilateral epithelial corneal dystrophy caused by Tyrosinemia (Richner-Hanhart-Syndrome) (author's transl)].
Topics: Age Factors; Amino Acid Metabolism, Inborn Errors; Animals; Corneal Dystrophies, Hereditary; Humans; Infant; Intellectual Disability; Keratoderma, Palmoplantar; Male; Rats; Syndrome; Tyrosine | 1978 |
[Tyrosinemia and Richner-Hanhart syndrome (an autosomal recessive hereditary metabolic disease of childhood with bilateral dendritic pseudokeratitis, keratosis palmaris et plantaris and mental deficiency)].
Topics: Amino Acid Metabolism, Inborn Errors; Child; Chromosome Aberrations; Chromosome Disorders; Genes, Recessive; Humans; Intellectual Disability; Keratitis, Dendritic; Keratoderma, Palmoplantar; Syndrome; Tyrosine | 1978 |
Tyrosinemia without liver or renal damage with plantar and palmar keratosis and keratitis (hypertyrosinemia type II).
Topics: Amino Acid Metabolism, Inborn Errors; Amino Acids; Child, Preschool; Humans; Hydroxy Acids; Infant; Intellectual Disability; Keratitis; Keratoderma, Palmoplantar; Male; Syndrome; Tyrosine | 1979 |
The Richner-Hanhart syndrome: report of a case with associated tyrosinemia.
Topics: Adolescent; Conjunctiva; Cornea; Corneal Opacity; Endothelium; Epithelium; Humans; Inclusion Bodies; Intellectual Disability; Keratoderma, Palmoplantar; Male; Parakeratosis; Phenylalanine; Syndrome; Tyrosine | 1976 |
[Richner-Hanhart's syndrome or oculo-cutaneous tyrosinosis (about one case) (author's transl)].
Topics: Child, Preschool; Female; Humans; Infant; Intellectual Disability; Keratitis, Dendritic; Keratosis; Syndrome; Tongue Diseases; Transaminases; Tyrosine | 1979 |
A syndrome of hereditary tyrosinemia in mink (Mustela vison Schreb.).
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Female; Male; Mink; Pedigree; Syndrome; Tyrosine | 1979 |
[Characteristics of tyrosine balance and oxidation in oligophrenia of different origin].
Topics: Adolescent; Ascorbic Acid; Child; Female; Homogentisic Acid; Humans; Intellectual Disability; Male; Phenylpyruvic Acids; Syndrome; Tyrosine | 1977 |
Some biochemical effects of chloral hydrate in an infant with a tyrosinemia-like syndrome.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Ascorbic Acid; Chloral Hydrate; Female; Humans; Hydrocephalus; Infant; Lactates; Methionine; Oxygenases; Phenylacetates; Phenylalanine; Phenylpyruvic Acids; Syndrome; Tyrosine | 1975 |
Richner-Hanhart's syndrome. Electron microscopic study of the skin lesion.
Topics: Amino Acid Metabolism, Inborn Errors; Child, Preschool; Humans; Keratoderma, Palmoplantar; Male; Skin; Syndrome; Tyrosine | 1990 |
[Type II oculo-cutaneous tyrosinosis or Richner-Hanhart syndrome--apropos of a case].
Topics: Amino Acid Metabolism, Inborn Errors; Corneal Ulcer; Diagnostic Errors; Female; Humans; Infant; Keratitis, Dendritic; Keratosis; Syndrome; Tyrosine; Tyrosine Transaminase | 1989 |
[4 cases of Richner-Hanhart syndrome (tyrosinemia type II) with neurological symptomatology in a Yugoslav family].
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Diseases in Twins; Female; Humans; Keratoderma, Palmoplantar; Male; Middle Aged; Nervous System Diseases; Neurologic Examination; Skin Transplantation; Syndrome; Tyrosine; Yugoslavia | 1988 |
Richner-Hanhart syndrome spares a plantar autograft.
Topics: Adult; Eye Diseases; Female; Graft Survival; Heel; Humans; Intellectual Disability; Keratoderma, Palmoplantar; Skin; Skin Transplantation; Syndrome; Tyrosine | 1985 |
Tyrosinemia II. A large North Carolina kindred.
Topics: Amino Acid Metabolism, Inborn Errors; Female; Heterozygote; Humans; Infant; Male; Middle Aged; North Carolina; Pedigree; Skin Diseases; Syndrome; Tyrosine | 1985 |
[Greenish blue man. Primary amyloidosis. Tyrosinuria].
Topics: Amino Acid Metabolism, Inborn Errors; Amyloidosis; Ascorbic Acid Deficiency; Autopsy; Digestive System; Humans; Malabsorption Syndromes; Male; Microscopy, Fluorescence; Middle Aged; Muscles; Myocardium; Phenylpyruvic Acids; Pigmentation Disorders; Syndrome; Tyrosine | 1972 |
Urinary metabolic studies in hereditary macular degeneration.
Topics: Albuminuria; Amino Acids; Carbohydrates; Cystinuria; Electrophoresis, Paper; Female; Glycosuria; Histidine; Humans; Keto Acids; Male; Pedigree; Phenylketonurias; Retinal Degeneration; Syndrome; Tyrosine | 1974 |
Narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings.
Topics: Adult; Amphetamine; Aspartic Acid; Body Weight; Cataplexy; Cerebrospinal Fluid Proteins; Dextroamphetamine; Electroencephalography; Feeding and Eating Disorders; Female; Homovanillic Acid; Humans; Libido; Male; Mental Disorders; Methionine; Middle Aged; Narcolepsy; Phenylalanine; Syndrome; Tyrosine | 1974 |
Tyrosinosis: a new variant.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Diet Therapy; Female; Humans; Pedigree; Syndrome; Tyrosine | 1973 |
May-Hegglin anomaly: a defect in megakaryocyte fragmentation?
Topics: Adenosine Diphosphate; Adolescent; Adult; Basophils; Blood Coagulation Tests; Blood Platelets; Cell Aggregation; Child; Cholesterol; Chromium Radioisotopes; Collagen; Eosinophils; Epinephrine; Female; Hematologic Diseases; Humans; Infant; Kinetics; Male; Megakaryocytes; Middle Aged; Neutrophils; Pedigree; Phospholipids; Platelet Adhesiveness; Prothrombin Time; Syndrome; Thrombocytopenia; Tyrosine | 1974 |
Classification of albinism in man.
Topics: Adolescent; Adult; Albinism; Animals; Blood Platelets; Bone Marrow Cells; Child; Child, Preschool; Female; Hair; Hemorrhagic Disorders; Humans; Macrophages; Male; Melanocyte-Stimulating Hormones; Mice; Microphthalmos; Mononuclear Phagocyte System; Skin Pigmentation; Syndrome; Tyrosine; Visual Acuity | 1971 |